Successful Treatment of Atopic Dermatitis with a Predominant Nipple Involvement by Abrocitinib During COVID-19 Pandemic: A Case Report.
Yan TengHui TangYong YuYibin FanXiaohua TaoDanfeng XuPublished in: Journal of asthma and allergy (2023)
JAK inhibitor abrocitinib might become a promising agent for the treatment with AD with a predominant uncommon region like nipple that might be resistant to conventional therapies during the COVID-19 pandemic.